دورية أكاديمية

Using biomarkers to allocate patients in a response-adaptive clinical trial.

التفاصيل البيبلوغرافية
العنوان: Using biomarkers to allocate patients in a response-adaptive clinical trial.
المؤلفون: Jackson, H., Bowen, S., Jaki, T.
المصدر: Communications in Statistics: Simulation & Computation; 2023, Vol. 52 Issue 12, p5946-5965, 20p
مصطلحات موضوعية: CLINICAL trials, RANDOMIZED controlled trials, BIOMARKERS, RARE diseases, CANCER patients
مستخلص: In this paper, we discuss a response adaptive randomization method, and why it should be used in clinical trials for rare diseases compared to a randomized controlled trial with equal fixed randomization. The developed method uses a patient’s biomarkers to alter the allocation probability to each treatment, in order to emphasize the benefit to the trial population. The method starts with an initial burn-in period of a small number of patients, who with equal probability, are allocated to each treatment. We then use a regression method to predict the best outcome of the next patient, using their biomarkers and the information from the previous patients. This estimated best treatment is assigned to the next patient with high probability. A completed clinical trial for the effect of catumaxomab on the survival of cancer patients is used as an example to demonstrate the use of the method and the differences to a controlled trial with equal allocation. Different regression procedures are investigated and compared to a randomized controlled trial, using efficacy and ethical measures. [ABSTRACT FROM AUTHOR]
Copyright of Communications in Statistics: Simulation & Computation is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:03610918
DOI:10.1080/03610918.2021.2004420